IOSP - Innospec Inc Stock Price, Fair Value and News

129.46USD-0.87 (-0.67%)Delayed as of 17 May 2024, 11:55 am ET

Market Summary

USD129.46-0.87

Delayedas of 17 May 2024, 11:55 am

-0.67%

IOSP Stock Price

View Fullscreen

IOSP RSI Chart

IOSP Valuation

Market Cap

3.2B

Price/Earnings (Trailing)

22.06

Price/Sales (Trailing)

1.68

EV/EBITDA

13.24

Price/Free Cashflow

12.21

IOSP Price/Sales (Trailing)

IOSP Profitability

EBT Margin

9.52%

Return on Equity

12.42%

Return on Assets

8.5%

Free Cashflow Yield

8.19%

IOSP Fundamentals

IOSP Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

-1.84%

Rev. Growth (Qtr)

1.11%

IOSP Earnings

Earnings (TTM)

147.3M

Earnings Growth (Yr)

24.7%

Earnings Growth (Qtr)

9.52%

Breaking Down IOSP Revenue

52 Week Range

91.74130.84

(Low)(High)

Last 7 days

3.1%

Last 30 days

7.6%

Last 90 days

4.6%

Trailing 12 Months

33.9%

How does IOSP drawdown profile look like?

IOSP Financial Health

Current Ratio

2.5

IOSP Investor Care

Dividend Yield

1.58%

Dividend/Share (TTM)

2.06

Shares Dilution (1Y)

0.26%

Diluted EPS (TTM)

5.89

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.9B	0	0	0
2023	2.0B	2.0B	2.0B	1.9B
2022	1.6B	1.7B	1.9B	2.0B
2021	1.2B	1.3B	1.4B	1.5B
2020	1.5B	1.4B	1.3B	1.2B
2019	1.5B	1.5B	1.5B	1.5B
2018	1.4B	1.4B	1.4B	1.5B
2017	965.6M	1.1B	1.2B	1.3B
2016	955.2M	940.3M	891.6M	883.4M
2015	1.0B	1.0B	1.1B	1.0B
2014	854.3M	889.9M	925.4M	960.9M
2013	775.0M	781.5M	790.9M	804.9M
2012	789.9M	781.9M	763.2M	776.4M
2011	705.0M	723.1M	751.2M	774.4M
2010	0	626.7M	655.0M	683.2M
2009	0	0	0	598.5M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Innospec Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 01, 2024	jones david b.	sold	-314,483	125	-2,500	svp, gc & cco
Feb 29, 2024	williams patrick	acquired	394,907	99.85	3,955	president & ceo
Feb 29, 2024	cleminson ian	acquired	92,960	99.85	931	vp & cfo
Feb 29, 2024	williams patrick	sold	-491,251	124	-3,955	president & ceo
Feb 29, 2024	cleminson ian	sold	-115,508	124	-931	vp & cfo
Feb 27, 2024	williams patrick	sold	-1,203,260	124	-9,667	president & ceo
Feb 26, 2024	padfield larry	acquired	-	-	782	-
Feb 26, 2024	boon philip john	acquired	-	-	1,563	executive vp business ops
Feb 26, 2024	paller robert i	acquired	-	-	782	-
Feb 26, 2024	parrette leslie j	acquired	-	-	782	-

Which funds bought or sold IOSP recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	AMUNDI	reduced	-31.97	-293,326	724,800	-%
May 15, 2024	Centiva Capital, LP	added	32.74	78,004	278,639	0.01%
May 15, 2024	DEUTSCHE BANK AG\	added	1.11	96,023	1,753,970	-%
May 15, 2024	STATE STREET CORP	added	1.6	7,451,470	125,750,000	0.01%
May 15, 2024	ALGERT GLOBAL LLC	reduced	-35.02	-3,012,000	6,395,000	0.25%
May 15, 2024	BANK OF AMERICA CORP /DE/	added	1.33	1,362,000	23,999,200	-%
May 15, 2024	TWO SIGMA ADVISERS, LP	reduced	-84.55	-1,270,870	244,986	-%
May 15, 2024	Cubist Systematic Strategies, LLC	added	998	4,404,320	4,824,020	0.03%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-99.95	-1,010,300	516	-%
May 15, 2024	B. Metzler seel. Sohn & Co. AG	reduced	-0.26	201,981	4,842,210	0.05%

Are Funds Buying or Selling IOSP?

Are funds buying IOSP calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own IOSP

No. of Funds

Unveiling Innospec Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.88%	2,953,893	SC 13G/A
Feb 09, 2024	wasatch advisors lp	-	0	SC 13G/A
Jan 22, 2024	blackrock inc.	16.0%	3,974,345	SC 13G/A
Jan 12, 2024	allspring global investments holdings, llc	9.40%	2,337,644	SC 13G/A
May 04, 2023	allspring global investments holdings, llc	10.07%	2,493,045	SC 13G/A
Feb 09, 2023	vanguard group inc	11.67%	2,889,993	SC 13G/A
Feb 08, 2023	wasatch advisors inc	-	0	SC 13G
Jan 31, 2023	royce & associates lp	3.52%	870,792	SC 13G/A
Jan 26, 2023	blackrock inc.	16.0%	3,963,193	SC 13G/A
Jan 20, 2023	blackrock inc.	16.0%	3,963,193	SC 13G/A

Recent SEC filings of Innospec Inc

View All Filings

Date Filed	Form Type	Document
May 16, 2024	4	Insider Trading
May 16, 2024	4	Insider Trading
May 14, 2024	8-K	Current Report
May 10, 2024	10-Q	Quarterly Report
May 10, 2024	8-K	Current Report
Apr 03, 2024	8-K	Current Report
Mar 28, 2024	ARS	ARS
Mar 28, 2024	DEF 14A	DEF 14A
Mar 28, 2024	DEFA14A	DEFA14A
Mar 06, 2024	4	Insider Trading

Peers (Alternatives to Innospec Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
APD	57.2B	12.2B	12.87%	-6.93%	23.16	4.71	-7.47%	13.44%
DOW	41.3B	43.5B	3.22%	14.01%	32.58	0.95	-18.61%	-57.39%
CE	17.0B	10.7B	0.39%	47.13%	8.54	1.59	7.11%	34.19%
AVTR	17.0B	6.9B	1.54%	23.18%	65.26	2.47	-6.48%	-57.90%
ALB	15.2B	8.4B	13.23%	-37.88%	45.02	1.81	-4.27%	-90.82%
EMN	11.8B	9.1B	3.76%	23.48%	12.72	1.29	-11.38%	33.67%
MID-CAP
CBT	5.6B	3.9B	9.59%	47.09%	12.57	1.44	-8.19%	39.97%
BCPC	5.1B	929.6M	7.55%	27.14%	44.23	5.46	-1.74%	15.81%
AVNT	4.2B	3.1B	9.31%	15.62%	39.66	1.33	-6.69%	-83.56%
ARCH	2.9B	3.0B	-3.97%	32.96%	9	0.98	-20.68%	-74.38%
SMALL-CAP
CCF	1.2B	404.0M	0.11%	32.60%	36.59	3	24.06%	-25.72%
ASIX	665.6M	1.5B	-8.16%	-27.13%	292.85	0.45	-21.27%	-97.94%
CMT	183.9M	336.4M	2.92%	4.09%	10.09	0.55	-12.92%	28.47%
AREC	103.7M	16.7M	-5.80%	-12.75%	-8.76	6.19	-57.58%	-718.66%
AMRS	3.7M	-	-80.00%	-99.58%	-0.01	0.01	-	-

Innospec Inc News

Latest updates

Innospec Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	1.1%	500	495	464	480	510	511	513	468	472	413	376	355	340	311	265	245	372	391	372	362	388
Gross Profit	0%	156	156	137	150	148	152	156	140	139	113	113	108	101	91.00	79.00	59.00	114	118	119	111	118
Operating Expenses	-5.4%	105	111	95.00	116	107	105	106	94.00	95.00	77.00	82.00	71.00	73.00	62.00	62.00	113	73.00	74.00	81.00	79.00	82.00
S&GA Expenses	-9.4%	93.00	102	84.00	106	96.00	97.00	96.00	83.00	85.00	70.00	71.00	63.00	64.00	55.00	54.00	64.00	64.00	66.00	71.00	71.00	73.00
R&D Expenses	32.6%	12.00	9.00	12.00	11.00	11.00	8.00	10.00	10.00	10.00	10.00	10.00	9.00	9.00	7.00	8.00	8.00	9.00	8.00	10.00	8.00	9.00
EBITDA Margin	5.8%	0.12*	0.11*	0.11*	0.11*	0.11*	0.12*	0.12*	0.12*	0.12*	0.12*	0.13*	0.13*	-	-	-	-	-	-	-	-	-
Income Taxes	85.3%	14.00	8.00	8.00	8.00	12.00	20.00	10.00	10.00	12.00	9.00	7.00	18.00	7.00	7.00	8.00	-14.10	11.00	12.00	8.00	8.00	10.00
Earnings Before Taxes	22.1%	55.00	45.00	48.00	37.00	45.00	45.00	49.00	42.00	48.00	33.00	31.00	40.00	31.00	29.00	20.00	-53.80	44.00	43.00	38.00	31.00	39.00
EBT Margin	6.4%	0.10*	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	0.09*	-	-	-	-	-	-	-	-	-
Net Income	9.5%	41.00	38.00	39.00	29.00	33.00	26.00	39.00	32.00	37.00	24.00	23.00	22.00	23.00	23.00	13.00	-39.70	33.00	31.00	30.00	22.00	29.00
Net Income Margin	6.4%	0.08*	0.07*	0.06*	0.06*	0.06*	0.07*	0.07*	0.07*	0.07*	0.06*	0.07*	0.06*	-	-	-	-	-	-	-	-	-
Free Cashflow	11.3%	81.00	72.00	58.00	55.00	22.00	78.00	40.00	-7.50	-29.00	69.00	3.00	-1.10	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.5%	1,733	1,707	1,619	1,611	1,624	1,604	1,669	1,638	1,624	1,571	1,492	1,462	1,426	1,397	1,344	1,339	1,455	1,469	1,494	1,490	1,527
Current Assets	3.1%	913	886	864	855	875	873	846	799	779	728	683	643	608	566	529	533	627	630	673	651	684
Cash Equivalents	32.6%	270	204	207	166	148	147	101	71.00	106	142	89.00	94.00	117	105	67.00	58.00	68.00	76.00	110	106	124
Inventory	1.4%	304	300	332	357	366	373	382	362	308	278	274	251	223	220	240	244	246	245	251	248	249
Net PPE	0.1%	269	268	245	242	234	221	207	210	214	214	213	214	210	211	204	199	198	199	195	200	200
Goodwill	-0.5%	398	399	358	361	360	359	352	357	362	364	366	368	367	371	367	363	361	363	361	364	363
Liabilities	-2.0%	547	558	491	516	544	563	577	569	555	538	-	-	-	-	-	-	-	-	612	627	678
Current Liabilities	-1.8%	365	372	344	365	382	406	381	369	352	337	308	291	274	252	230	219	266	304	297	304	300
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39.00	59.00	59.00	131	137	186
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22.00	22.00
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39.00	59.00	59.00	131	137	186
Shareholder's Equity	3.4%	1,186	1,147	1,125	1,095	1,081	1,038	1,092	1,069	1,069	1,033	993	974	959	945	926	900	944	919	882	863	849
Retained Earnings	4.0%	1,070	1,028	1,008	969	957	924	915	876	859	823	814	790	782	759	749	736	789	756	737	707	697
Additional Paid-In Capital	0.4%	362	361	359	357	355	354	352	351	350	347	341	340	338	336	334	333	331	330	329	328	326
Shares Outstanding	0.2%	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	25.00	-	-	-	-	-	-	-	-	-
Minority Interest	4.0%	3.00	3.00	3.00	3.00	2.00	2.00	3.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	1.00
Float	-	-	-	-	1,349	-	-	-	1,409	-	-	-	1,245	-	-	-	1,061	-	-	-	1,133	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	11.3%	80,600	72,400	58,100	55,000	21,800	78,400	39,800	-7,500	-29,000	68,800	2,800	-1,100	22,700	58,200	55,500	29,800	2,400	58,400	40,000	50,000	13,200
Share Based Compensation	0%	2,100	2,100	2,000	2,000	1,900	2,000	1,500	1,500	1,700	-200	1,700	1,300	1,600	1,400	1,600	1,600	1,200	1,700	1,700	1,600	1,600
Cashflow From Investing	74.4%	-14,300	-55,800	-16,700	-17,300	-22,000	-15,100	-9,600	-9,000	-8,400	-9,200	-7,800	-8,900	-10,300	-8,000	-7,100	-6,800	-7,800	-7,300	-6,800	-5,700	-11,200
Cashflow From Financing	102.5%	500	-20,400	200	-19,200	400	-17,000	-400	-17,200	900	-6,800	100	-13,000	-300	-12,000	-40,200	-33,000	-1,600	-86,100	-28,600	-61,700	-1,500
Dividend Payments	-100.0%	-	17,900	-	-	-	16,100	-	-	-	14,800	-	-	-	12,800	-	-	-	12,800	-	-	-
Buy Backs	300.0%	400	100	-	700	300	900	2,300	1,800	900	-	-	200	600	-	-	-	2,100	200	100	200	1,900

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

IOSP Income Statement

2024-03-31

Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 500.2	$ 509.6
Cost of goods sold	(344.5)	(361.8)
Gross profit	155.7	147.8
Operating expenses:
Selling, general and administrative	(92.7)	(96.2)
Research and development	(11.8)	(10.6)
Adjustment to fair value of contingent consideration	(0.8)	0.0
Profit on disposal of property, plant and equipment	0.1	0.0
Total operating expenses	(105.2)	(106.8)
Operating income	50.5	41.0
Other income, net	2.7	3.7
Interest income, net	2.1	0.3
Income before income tax expense	55.3	45.0
Income tax expense	(13.9)	(11.8)
Net income	$ 41.4	$ 33.2
Earnings per share:
Basic	$ 1.66	$ 1.34
Diluted	$ 1.65	$ 1.33
Weighted average shares outstanding (in thousands):
Basic	24,893	24,801
Diluted	25,066	24,962

IOSP Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 270.1	$ 203.7
Trade and other accounts receivable (less allowances of $9.0 million and $10.3 million, respectively)	318.2	359.8
Inventories (less allowances of $26.4 million and $28.1 million, respectively):
Finished goods	216.5	215.7
Raw materials	87.8	84.4
Total inventories	304.3	300.1
Prepaid expenses	15.0	18.7
Prepaid income taxes	4.4	2.8
Other current assets	0.9	0.6
Total current assets	912.9	885.7
Net property, plant and equipment	268.7	268.3
Operating leases right-of-use assets	43.5	45.1
Goodwill	397.5	399.3
Other intangible assets	57.7	57.3
Deferred tax assets	10.4	10.4
Pension asset	36.1	35.1
Other non-current assets	6.0	6.2
Total assets	1,732.8	1,707.4
Current liabilities:
Accounts payable	166.4	163.6
Accrued liabilities	163.6	185.9
Current portion of operating lease liabilities	13.6	13.6
Current portion of plant closure provisions	4.6	4.6
Current portion of accrued income taxes	12.2	2.6
Current portion of unrecognized tax benefits	4.5	1.2
Total current liabilities	364.9	371.5
Operating lease liabilities, net of current portion	30.0	31.6
Plant closure provisions, net of current portion	56.6	57.0
Accrued income taxes, net of current portion	11.6	11.6
Unrecognized tax benefits, net of current portion	10.5	13.6
Deferred tax liabilities	34.1	33.5
Pension liabilities and post-employment benefits	13.0	13.3
Acquisition-related contingent consideration	23.5	23.4
Other non-current liabilities	2.4	2.3
Total liabilities	546.6	557.8
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	362.4	361.0
Treasury stock (4,621,255 and 4,686,511 shares at cost, respectively)	(93.3)	(94.3)
Retained earnings	1,069.6	1,028.2
Accumulated other comprehensive loss	(155.4)	(148.1)
Total Innospec stockholders' equity	1,183.6	1,147.1
Non-controlling interest	2.6	2.5
Total equity	1,186.2	1,149.6
Total liabilities and equity	$ 1,732.8	$ 1,707.4

About Innospec Inc

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

CEO	Mr. Patrick S. Williams
WEBSITE	https://innospec.com
INDUSTRY	Chemicals
EMPLOYEES	2100

Innospec Inc Frequently Asked Questions

What is the ticker symbol for Innospec Inc? What does IOSP stand for in stocks?

IOSP is the stock ticker symbol of Innospec Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Innospec Inc (IOSP)?

As of Thu May 16 2024, market cap of Innospec Inc is 3.25 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IOSP stock?

You can check IOSP's fair value in chart for subscribers.

What is the fair value of IOSP stock?

You can check IOSP's fair value in chart for subscribers. The fair value of Innospec Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Innospec Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for IOSP so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Innospec Inc a good stock to buy?

The fair value guage provides a quick view whether IOSP is over valued or under valued. Whether Innospec Inc is cheap or expensive depends on the assumptions which impact Innospec Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IOSP.

What is Innospec Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 16 2024, IOSP's PE ratio (Price to Earnings) is 22.06 and Price to Sales (PS) ratio is 1.68. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IOSP PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Innospec Inc's stock?

In the past 10 years, Innospec Inc has provided 0.133 (multiply by 100 for percentage) rate of return.